OakChart

Zoetis Inc

ZTSHealthcare·Drug Manufacturers - Specialty & Generic·USA·Large·NYSE·Nov 11 • 3:59 PM ET

82.57+0.11 (0.13%)
2026-11-12 00:56 CET
Market cap
33,504.82 USD m
Revenue, TTM
9,508.00 USD m
Net income, TTM
2,486.00 USD m
Free cash flow, TTM
2,278.00 USD m
EPS diluted, TTM
5.89
P/E
14.02
Compare

Price

ZTS against its 20, 50 and 200-day averages
2050200miss
80.00100.00120.009.2M18.4MVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26ZTSclose 82.5720-day 80.9950-day 76.00200-day 91.8782.5752w high52w low

37.7% under the 52-week high of 132.49 on 12 Feb 2026. 52-week low 68.77 on 2 Oct 2026. Last 15 sessions, 15.9% high to low

Volume 0.96× normal · the line is the 50-bar volume average

Profile

ZTS
52-week range, 22% of the way up
68.77132.49

Zoetis, Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health technology. It operates through the United States and International geographical segments. The company was founded in 1952 and is headquartered in Parsippany, NJ.

IndexS&P 500, RUI
Employees14500
IPOFeb 01, 2013
Beta0.67
ATR, 14d2.71
Rel volume0.96
Short float4.13%
Insider own0.23%
Inst own101.38%

Snapshot

6 groups

Valuation

IndexS&P 500, RUI
Market Cap33.55B
Enterprise Value41.25B
Income2.49B
Sales9.51B
Book/sh8.11
Cash/sh3.77
Dividend Est.2.11 (2.56%)
Dividend TTM2.12 (2.57%)
Dividend Ex-DateOct 30, 2026
Dividend Gr. 3/5Y14.57% 19.02%
Payout33.71%
Employees14500
IPOFeb 01, 2013

Ratios

P/E14.02
Forward P/E13.09
PEG8.08
P/S3.53
P/B10.19
P/C21.88
P/FCF14.73
EV/EBITDA10.23
EV/Sales4.34
Quick Ratio1.40
Current Ratio2.35
Debt/Eq2.80
LT Debt/Eq2.57
Option/ShortYes / Yes

Earnings

EPS (ttm)5.89
EPS next Y6.31
EPS next Q1.21
EPS this Y-1.57%
EPS next Y-0.00%
EPS next 5Y1.62%
EPS past 3/5Y10.25% 11.96%
Sales past 3/5Y5.42% 7.24%
EPS Y/Y TTM-0.84%
Sales Y/Y TTM1.18%
EPS Q/Q-11.73%
Sales Q/Q-0.38%
EarningsNov 05 BMO
EPS/Sales Surpr.15.74% 3.79%

Ownership

Insider Own0.23%
Insider Trans1.26%
Inst Own101.38%
Inst Trans-2.62%
ROA16.44%
ROE57.14%
ROIC21.09%
Gross Margin70.05%
Oper. Margin37.37%
Profit Margin26.15%
SMA201.95%
SMA508.64%
SMA200-10.12%
Trades-

Technical

Shs Outstand407.49M
Shs Float405.38M
Short Float4.13%
Short Ratio3.61
Short Interest16.72M
52W High132.49 -37.68%
52W Low68.77 20.07%
Volatility4.80% 2.93%
ATR (14)2.71
RSI (14)56.52
Beta0.67
Rel Volume0.96
Avg Volume4.64M
Volume4,449,120

Performance

Perf Week-7.43%
Perf Month11.13%
Perf Quarter8.87%
Perf Half Y11.07%
Perf YTD-34.37%
Perf Year-31.26%
Perf 3Y-51.23%
Perf 5Y-61.72%
Perf 10Y63.15%
Recom2.44
Target Price88.55
Prev Close82.46
Price82.57
Change %0.13%

Analyst ratings

latest 10 of 20
DateActionAnalystRating changeTargetImplied
Oct 20, 2026DowngradeJJefferiesBuy → Hold$83+0.5%
Oct 16, 2026InitiatedGGoldmanNeutral$74-10.4%
Aug 06, 2026DowngradeWWilliam BlairOutperform → Mkt Perform
May 27, 2026DowngradeAArgusBuy → Hold
Apr 15, 2026InitiatedCCitigroupBuy$145+75.6%
Jan 22, 2026DowngradePPiper SandlerOverweight → Neutral$135+63.5%
Dec 15, 2025DowngradeBBofA SecuritiesBuy → Neutral$135+63.5%
Dec 09, 2025InitiatedBBarclaysEqual Weight$136+64.7%
Nov 21, 2025InitiatedKKeyBanc Capital MarketsSector Weight
Jul 17, 2025DowngradeLLeerink PartnersOutperform → Market Perform$155+87.7%

Peers

Mkt cap
TickerCompanyMkt cap
ELANElanco Animal Health Inc13.24B
PAHCPhibro Animal Health Corp1.43B
IDXXIdexx Laboratories Inc55.35B
MRKMerck & Co Inc362.83B
CORCencora Inc66.77B
NEOGNeogen Corp2.53B
PFEPfizer Inc167.86B
CHWYChewy Inc9.30B
TRUPTrupanion Inc1.49B
WOOFPetco Health and Wellness Co Inc824.89M

Insider trading

8 filings
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
DAMELIO FRANK ADirectorMay 13 '26Buy75.396,650501,34421,458May 13 04:35 PM
Bisaro PaulDirectorMay 13 '26Buy75.882,000151,75027,862May 13 04:35 PM
MCCALLISTER MICHAEL BDirectorMay 11 '26Buy77.763,000233,27324,524May 12 07:26 PM
PECK KRISTIN CChief Executive OfficerFeb 17 '26Option Exercise41.8320,000836,600121,337Feb 17 04:22 PM
PECK KRISTIN CChief Executive OfficerFeb 17 '26Sale127.0520,0002,540,964101,337Feb 17 04:22 PM
Polzer Robert JOfficerFeb 17 '26Proposed Sale127.342,346298,742Feb 17 04:14 PM
PECK KRISTIN COfficerFeb 17 '26Proposed Sale127.0520,0002,540,964Feb 17 04:13 PM
Polzer Robert JOfficerFeb 13 '26Proposed Sale129.093,662472,728Feb 13 04:26 PM

Held by

AUM
TickerCompanyAUM
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
VOOVanguard S&P 500 ETFAUM: 1054.75B
VOVanguard Morningstar Mid-Cap ETFAUM: 107.07B
IVViShares Core S&P 500 ETFAUM: 871.38B
SPYSPDR S&P 500 ETF TrustAUM: 793.23B
MOATVanEck Morningstar Wide Moat ETFAUM: 12.18B
XLVState Street Health Care Select Sector SPDR ETFAUM: 50.35B
VTVVanguard Morningstar Value ETFAUM: 196.23B
RSPInvesco S&P 500 Equal Weight ETFAUM: 104.94B
VFLOVictoryShares Free Cash Flow ETFAUM: 12.50B

News

latest 14 of 100

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-11-051.7501.5121.4402,3912,30413
2026Q22026-08-061.8701.8521.6542,4682,50114
2026Q12026-05-071.5301.6041.4232,2622,30115
2025Q42026-02-121.4801.4021.3752,3872,36016
2025Q32025-11-041.7001.6211.6272,4002,41013
2025Q22025-08-051.7601.6211.6122,4602,41013
2025Q12025-05-061.4801.4101.4092,2202,19013
2024Q42025-02-131.4001.3621.2882,3172,29713
2024Q32024-11-041.5801.4561.5042,3882,28912
2024Q22024-08-061.5601.4851.3682,3612,31313
2024Q12024-05-021.3801.3461.3062,1902,15311
2023Q42024-02-131.2401.3161.1412,2132,18811
2023Q32023-11-021.3601.3561.2922,1512,17211
2023Q22023-08-081.4101.3131.4502,1802,15612
2023Q12023-05-041.3101.2451.1882,0002,01413
2022Q42023-02-141.1501.1510.9882,0402,00314

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2019FY3.6403.6103.1136,2606,225
2020FY3.8503.7963.4236,6756,600
2021FY4.7004.6684.2737,7767,743
2022FY4.8804.8804.4948,0808,042
2023FY5.3205.4115.0718,5448,523
2024FY5.9205.8885.4669,2569,249
2025FY6.4106.3406.0209,4679,442
2026FY-6.309--9,289
2027FY-6.309--9,292
2028FY-6.726--9,622
2029FY-7.880--10,118
2030FY-8.605--10,507

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-11-09110102,1772,1412,235
2026Q4S2026-11-0611092,1832,1412,258
2026Q4S2026-11-0511082,1902,1452,258
2026Q4S2026-11-0411012,2342,1832,321
2026Q4S2026-10-2411022,2342,1832,321
2026Q4S2026-10-2311032,2342,1832,321
2026Q4S2026-10-2011022,2392,1832,321
2026Q4S2026-10-19110102,2392,1832,321
2026Q4S2026-10-16110102,2392,1832,321
2026Q4S2026-10-15120112,2342,1732,321
2026Q4S2026-10-09110112,2262,1732,273
2026Q4S2026-09-30110112,2262,1732,273
2026Q4S2026-09-28110112,2242,1732,273
2026Q4S2026-09-25110112,2252,1732,273

Estimate history

EPS, annual1.752.9333.1133.4234.2734.4945.0715.4666.0235.8878
Period201720182019202020212022202320242025TTM
EPS, quarterly1.5041.2881.4091.6121.6271.3751.4231.6541.436
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual5307582562606675777680808544925694679508
Period201720182019202020212022202320242025TTM
Sales, quarterly238823172220246024002387226224682391
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual486.13479.562475.528475.318472.574501.891458.367448.473424.928407.487
Period201720182019202020212022202320242025MRQ
Shares, quarterly451.55448.473446.04443.946441.464424.928420.348414.154407.487
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue9,508.009,467.009,256.008,544.008,080.007,776.006,675.006,260.005,825.00
Cost of Goods Sold Incl. D&A2,848.002,794.002,860.002,710.002,604.002,464.002,217.002,147.002,028.00
Gross Profit6,660.006,673.006,396.005,834.005,476.005,312.004,458.004,113.003,797.00
Selling, General and Administrative Excl. Other3,107.003,076.003,004.002,765.002,548.002,509.002,189.002,095.001,916.00
Research and Development726.00698.00686.00614.00539.00508.00463.00457.00432.00
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income3,553.003,597.003,392.003,069.002,928.002,803.002,269.002,018.001,881.00
Interest Expense264.00243.00242.00258.00237.00236.00249.00242.00212.00
Unusual Expense230.008.0062.0095.0099.0081.0043.0032.0056.00
Net Income Before Taxes3,114.003,360.003,133.002,936.002,656.002,488.001,996.001,801.001,690.00
Income Taxes628.00687.00637.00596.00545.00454.00360.00301.00266.00
Consolidated Net Income2,486.002,673.002,496.002,340.002,111.002,034.001,636.001,500.001,424.00
Net Income From Continuing Operations2,486.002,673.002,486.002,344.002,114.002,037.001,638.001,500.001,428.00
Net Income2,486.002,673.002,486.002,344.002,114.002,037.001,638.001,500.001,428.00
EPS (Recurring)6.436.045.565.214.644.393.493.163.01
EPS (Basic, Before Extraordinaries)5.896.035.475.084.514.293.443.142.96
EPS (Diluted)5.896.025.475.074.494.273.423.112.93
EBITDA4,031.004,084.003,889.003,560.003,393.003,251.002,710.002,430.002,189.00
Non-Operating Income (Expense)55.0014.0045.00220.0064.002.0019.0057.0077.00
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense84.6773.0065.0052.0054.0051.0052.0057.0046.00
Price To Earnings Ratio14.0114.0130.6340.1433.5057.1248.3642.5029.13
Price To Sales Ratio3.025.908.0110.688.5314.9611.8710.197.15
Gross Margin70.0570.4969.1068.2867.7768.3166.7965.7065.18
Operating Margin37.3738.0036.6535.9236.2436.0533.9932.2432.29
Net Margin26.1528.2326.8627.4326.1626.2024.5423.9624.52
Shares Outstanding407.49424.93448.47458.37501.89472.57475.32475.53479.56
Market Capitalization33,504.8233,504.8273,508.3190,615.3368,302.85115,456.9478,656.8563,038.1741,097.78

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue2,391.002,468.002,262.002,387.002,400.002,460.002,220.002,317.00
Cost of Goods Sold Incl. D&A729.00704.00672.00743.00715.00682.00654.00741.00
Gross Profit1,662.001,764.001,590.001,644.001,685.001,778.001,566.001,576.00
Selling, General and Administrative Excl. Other756.00765.00768.00818.00749.00789.00720.00811.00
Research and Development174.00173.00180.00199.00170.00172.00157.00186.00
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income906.00999.00822.00826.00936.00989.00846.00765.00
Interest Expense68.0067.0067.0062.0064.0058.0059.0056.00
Unusual Expense100.0093.008.0029.00-7.00-25.0011.0024.00
Net Income Before Taxes729.00866.00758.00761.00887.00902.00810.00732.00
Income Taxes138.00175.00157.00158.00166.00184.00179.00151.00
Consolidated Net Income591.00691.00601.00603.00721.00718.00631.00581.00
Net Income From Continuing Operations591.00691.00601.00603.00721.00718.00631.00581.00
Net Income591.00691.00601.00603.00721.00718.00631.00581.00
EPS (Recurring)1.611.811.441.421.621.571.431.33
EPS (Basic, Before Extraordinaries)1.441.651.421.381.631.611.411.29
EPS (Diluted)1.441.651.421.371.631.611.411.29
EBITDA1,025.001,118.00941.00947.001,060.001,112.00965.00888.00
Non-Operating Income (Expense)-9.0027.0011.0026.008.00-54.0034.0047.00
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense27.0020.5419.7517.3817.3817.3813.4315.01
Price To Earnings Ratio14.0111.9119.6321.2025.1828.0030.1230.63
Price To Sales Ratio3.023.155.255.836.907.407.947.94
Gross Margin69.5171.4770.2968.8770.2172.2870.5468.02
Operating Margin37.8940.4836.3434.6039.0040.2038.1133.02
Net Margin24.7228.0026.5725.2630.0429.1928.4225.08
Shares Outstanding407.49414.15420.35424.93441.46443.95446.04448.47
Market Capitalization33,504.8230,125.7249,899.7555,447.9964,846.5469,430.1973,728.9573,508.31

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments2,312.001,987.002,041.003,581.003,485.003,604.001,934.001,701.001,564.00
Short Term Receivables1,590.001,316.001,304.001,215.001,133.001,013.001,086.001,036.00998.00
Inventories2,430.002,306.002,564.002,345.001,923.001,628.001,410.001,391.001,427.00
Other Current Assets436.00377.00434.00365.00389.00366.00318.00271.00228.00
Total Current Assets6,768.005,986.006,343.007,506.006,930.006,611.004,748.004,399.004,217.00
Net Property, Plant & Equipment3,969.003,610.003,434.002,973.002,603.002,394.002,129.001,658.001,435.00
Total Investments and Advances0.0030.0023.0031.0033.0022.0025.0010.000.00
Intangible Assets3,765.003,851.004,097.004,126.004,156.004,404.004,482.004,565.002,779.00
Deferred Tax Assets637.00540.00206.00173.00100.0094.0088.0064.0083.00
Other Assets328.00220.00183.00116.0078.0084.0073.0081.0072.00
Total Assets15,467.0014,237.0014,286.0014,925.0013,900.0013,609.0011,545.0010,777.008,586.00
Short Term Debt Incl. Current Port. of LT Debt53.001,402.0052.001,395.0041.00644.00535.009.000.00
Accounts Payable487.00433.00411.00405.00436.00457.00301.00313.00261.00
Income Tax Payable147.0093.00110.00157.0038.0046.0036.0035.0060.00
Other Current Liabilities1,548.001,484.001,316.001,210.001,282.001,023.00934.00866.00773.00
Total Current Liabilities2,235.003,412.001,889.003,167.001,797.002,170.001,806.001,223.001,094.00
Long Term Debt9,244.005,401.006,760.006,738.006,743.006,758.006,111.006,443.004,953.00
Provision for Risks Charges345.00339.00351.00337.00360.00379.00374.00363.00273.00
Deferred Tax Liabilities139.00167.00146.00142.00320.00378.00434.00474.00380.00
Other Liabilities173.00148.00149.00138.00136.00151.00112.0089.00100.00
Total Liabilities12,136.009,467.009,295.0010,522.009,356.009,836.008,837.008,592.006,800.00
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity3,331.004,770.004,997.004,405.004,543.003,769.002,708.002,185.001,770.00
Total Shareholders Equity3,331.004,770.004,997.004,405.004,543.003,769.002,708.002,185.001,770.00
Accumulated Minority Interest0.000.00-6.00-2.001.004.000.000.0016.00
Total Equity3,331.004,770.004,991.004,403.004,544.003,773.002,708.002,185.001,786.00
Total Liabilities & Stockholders Equity15,467.0014,237.0014,286.0014,925.0013,900.0013,609.0011,545.0010,777.008,586.00
Book Value Per Share7.8410.6410.908.789.617.935.694.563.64
Tangible Book Value Per Share-1.022.051.960.560.82-1.34-3.73-4.96-2.08
Full-Time Employees14,50013,80014,10013,80012,10011,30010,60010,0009,200
Price to Book Ratio10.1714.0617.8614.6625.3820.8723.2418.7717.67
Return on Assets18.0017.4316.0514.6714.8113.0213.4414.7510.64
Return on Equity65.9950.9149.8647.2549.0150.5861.3172.2153.05
Return on Invested Capital21.2624.4419.9418.9718.0515.5617.0116.5512.85
Quick Ratio1.941.082.001.632.792.301.852.462.55
Current Ratio3.031.753.362.373.863.052.633.603.85

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income2,486.002,673.002,496.002,340.002,111.002,034.001,636.001,500.001,424.00
Depreciation478.00487.00497.00491.00465.00448.00441.00412.00308.00
Other Funds (Non Cash)281.00204.00219.0095.00321.00154.00196.00113.0058.00
Funds from Operations3,186.003,312.002,874.002,865.002,611.002,556.002,211.001,946.001,678.00
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital-413.00-408.0079.00-512.00-699.00-343.00-85.00-151.00112.00
Cash from Operating Activities2,773.002,904.002,953.002,353.001,912.002,213.002,126.001,795.001,790.00
Capital Expenditures-495.00-621.00-655.00-732.00-586.00-477.00-453.00-460.00-338.00
Net Assets From Acquisitions-169.00-28.00-8.00-155.00-312.00-14.00-113.00-195.00-2,024.00
Sale of Fixed Assets and Businesses10.000.00294.00100.001.002.0024.0021.0056.00
Purchase or Sale of Investments-211.00-7.00-5.00-4.00-9.00-12.000.00101.0028.00
Purchase of Investments-211.00-7.00-5.00-4.00-9.00-12.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.000.00101.0028.00
Other Uses12.00-93.00-3.000.000.00-1.00-27.00-8.00-7.00
Other Sources38.001.0062.0014.0023.0044.000.0037.000.00
Cash from Investing Activities-815.00-748.00-315.00-777.00-883.00-458.00-569.00-504.00-2,285.00
Cash Dividends Paid-886.00-889.00-786.00-692.00-611.00-474.00-380.00-314.00-243.00
Change in Capital Stock-3,750.00-3,235.00-1,858.00-1,092.00-1,594.00-743.00-250.00-619.00-679.00
Repurchase of Common Pref Stock-3,750.00-3,235.00-1,858.00-1,092.00-1,594.00-743.00-250.00-626.00-698.00
Sale of Common Pref Stock0.000.000.000.000.000.000.007.0019.00
Proceedsfrom Stock Options0.000.000.000.000.000.000.000.000.00
Issuance or Reduction of Debt, Net1,784.002,268.00-3.00-1,349.001,340.00-604.00732.00-9.001,493.00
Change in Long Term Debt1,784.002,268.000.00-1,350.001,338.00-600.00728.000.001,485.00
Issuance of Long Term Debt1,971.003,805.000.000.001,338.000.001,228.000.001,485.00
Reduction of Long Term Debt-187.00-1,537.000.00-1,350.000.00-600.00-500.000.000.00
Net Financing Active Other Cash Flow-14.00-14.00-13.0024.00-39.00-41.0018.00-9.00-12.00
Other Financing Activities Uses-14.00-14.00-13.00-3.00-39.00-41.00-2.00-9.00-12.00
Cash from Financing Activities-2,866.00-1,870.00-2,660.00-3,109.00-904.00-1,862.00120.00-951.00559.00
Exchange Rate Effect19.0039.00-32.00-7.00-29.00-12.00-7.00-8.00-26.00
Net Change in Cash-889.00325.00-54.00-1,540.0096.00-119.001,670.00332.0038.00
Free Cash Flow2,278.002,283.002,298.001,621.001,326.001,736.001,673.001,335.001,452.00
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Price to Free Cash Flow20.6540.0649.0198.2196.4192.1861.2662.4534.45
Deferred Taxes & Investment Tax Credit--52.00-338.00-61.00-286.00-80.00-62.00-79.00-112.00

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments1,533.001,676.001,941.002,312.002,084.001,435.00
Short Term Receivables1,692.001,571.001,506.001,590.001,541.001,540.00
Inventories2,536.002,574.002,550.002,430.002,465.002,439.00
Other Current Assets532.00535.00477.00436.00493.00509.00
Total Current Assets6,293.006,356.006,474.006,768.006,583.005,923.00
Net Property, Plant & Equipment4,051.004,031.004,001.003,969.003,892.003,839.00
Total Investments and Advances4.003.003.000.001.000.00
Intangible Assets3,738.003,689.003,737.003,765.003,804.003,833.00
Deferred Tax Assets608.00617.00591.00637.00587.00617.00
Other Assets394.00381.00348.00328.00292.00267.00
Total Assets15,088.0015,077.0015,154.0015,467.0015,159.0014,479.00
Short Term Debt Incl. Current Port. of LT Debt750.000.000.0053.000.001,350.00
Accounts Payable419.00452.00507.00487.00410.00508.00
Income Tax Payable201.00138.00211.00147.00152.0093.00
Other Current Liabilities1,312.001,471.001,335.001,548.001,245.001,415.00
Total Current Liabilities2,682.002,061.002,053.002,235.001,807.003,366.00
Long Term Debt8,487.009,238.009,238.009,244.007,273.005,441.00
Provision for Risks Charges297.00290.00283.00345.00272.00267.00
Deferred Tax Liabilities104.00122.00130.00139.00147.00156.00
Other Liabilities215.00218.00217.00173.00262.00272.00
Total Liabilities11,785.0011,929.0011,921.0012,136.009,761.009,502.00
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity3,303.003,148.003,233.003,331.005,398.004,977.00
Total Shareholders Equity3,303.003,148.003,233.003,331.005,398.004,977.00
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity3,303.003,148.003,233.003,331.005,398.004,977.00
Total Liabilities & Stockholders Equity15,088.0015,077.0015,154.0015,467.0015,159.0014,479.00
Book Value Per Share8.117.607.697.8412.2311.21
Tangible Book Value Per Share-1.07-1.31-1.20-1.023.612.58
Full-Time Employees---14,500--
Price to Book Ratio10.179.3415.0810.2913.0514.94
Return on Assets16.4417.7018.0718.0017.9618.24
Return on Equity57.1464.3967.0165.9949.8752.54
Return on Invested Capital5.015.584.824.805.696.89
Quick Ratio1.401.841.911.942.281.04
Current Ratio2.353.083.153.033.641.76

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income591.00691.00601.00603.00721.00718.00
Depreciation119.00119.00119.00121.00124.00123.00
Other Funds (Non Cash)166.0036.0032.0047.0055.0067.00
Funds from Operations864.00813.00786.00723.00884.00901.00
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital-40.00-158.00-385.00170.0054.00-415.00
Cash from Operating Activities824.00655.00401.00893.00938.00486.00
Capital Expenditures-107.00-117.00-110.00-161.00-133.00-178.00
Net Assets From Acquisitions-155.000.000.00-14.000.00-14.00
Sale of Fixed Assets and Businesses0.001.0010.00-1.001.000.00
Purchase or Sale of Investments-2.00-206.00-2.00-1.00-3.000.00
Purchase of Investments-2.00-206.00-2.00-1.00-3.000.00
Sale Or Maturity of Investments0.000.000.000.00--
Other Uses0.001.00-1.0012.00-27.00-54.00
Other Sources2.0021.0016.00-1.002.00-1.00
Cash from Investing Activities-262.00-300.00-87.00-166.00-160.00-247.00
Cash Dividends Paid-219.00-223.00-224.00-220.00-222.00-223.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock-500.00-584.00-606.00-2,060.00-394.00-338.00
Repurchase of Common Pref Stock-500.00-584.00-606.00-2,060.00-394.00-338.00
Sale of Common Pref Stock0.000.000.000.000.000.00
Proceedsfrom Stock Options0.000.000.000.000.000.00
Issuance or Reduction of Debt, Net0.000.000.001,784.00484.000.00
Change in Long Term Debt0.000.000.001,784.00484.000.00
Issuance of Long Term Debt0.000.000.001,971.001,834.000.00
Reduction of Long Term Debt0.000.000.00-187.00-1,350.000.00
Net Financing Active Other Cash Flow1.00-6.00-10.001.00-2.00-3.00
Other Financing Activities Uses1.00-6.00-10.001.00-2.00-3.00
Cash from Financing Activities-718.00-813.00-840.00-495.00-134.00-564.00
Exchange Rate Effect13.00-7.0017.00-4.005.0039.00
Net Change in Cash-143.00-465.00-509.00228.00649.00-286.00
Free Cash Flow717.00538.00291.00732.00805.00308.00
Price to Free Cash Flow20.6520.3240.0439.5947.0950.31

Revenue breakdown

Animal Health Diagnostics2024: 386.00M 2025: 434.00M
Anti-infective Products2024: 1.10B 2025: 1.04B
Contract Manufacturing and Human Health Diagnostics2024: 80.00M 2025: 116.00M
Dermatology2024: 1.66B 2025: 1.75B
Medicated Feed Additives2024: 293.00M 2025: 27.00M
Other Non Pharmaceuticals2024: 253.00M 2025: 263.00M
Other Pharmaceuticals2024: 658.00M 2025: 697.00M
Pain & Sedation2024: 851.00M 2025: 840.00M
Parasiticides2024: 2.15B 2025: 2.34B
Vaccines2024: 1.83B 2025: 1.96B
Consolidation, Policy2024: 80.00M 2025: 116.00M
International2024: 4.10B 2025: 4.25B
United States2024: 5.07B 2025: 5.10B

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-304.13%16.7M405.4M4.98M
2026-10-154.25%17.5M412.3M5.34M
2026-09-304.47%18.4M412.3M5.54M
2026-09-154.22%17.4M412.3M6.15M
2026-08-314.71%19.4M412.3M6.48M
2026-08-144.07%16.8M412.3M7.00M
2026-07-315.20%21.4M410.9M7.50M
2026-07-154.51%18.8M416.8M7.24M
2026-06-303.82%15.9M416.8M6.72M
2026-06-153.87%16.1M416.7M6.12M
2026-05-293.23%13.5M416.8M5.66M
2026-05-153.21%13.4M416.8M5.18M
2026-04-303.55%14.8M416.9M4.03M
2026-04-153.22%13.5M419.7M4.21M
2026-03-313.59%15.1M421.3M4.51M
2026-03-133.73%15.7M421.3M4.91M
2026-02-274.11%17.3M421.3M5.10M
2026-02-133.88%16.3M421.3M5.24M
2026-01-303.22%14.1M439.9M5.39M
2026-01-153.54%15.6M439.9M4.96M

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call40.0040.5044.3038.603.7952.000.000.994-0.0220.002
call45.0035.5039.200.003.2220.000.000.993-0.0220.002
call50.0030.5034.300.002.8150.000.000.992-0.0220.003
call55.0026.0029.2023.102.3490.000.000.978-0.0510.007
call60.0021.0024.3027.802.0027.000.000.973-0.0500.008
call65.0015.8018.7016.951.41187.004.000.967-0.0470.009
call70.0010.9013.2011.350.8987683.000.956-0.0440.012
call75.006.308.106.800.5771,4875.000.910-0.0580.021
call80.002.953.903.230.4722,53143.000.704-0.1040.044
call85.000.700.900.800.3583,2891650.341-0.1120.047
call90.000.050.200.150.3971,59345.000.097-0.0520.022
call95.000.000.150.100.54283115.000.053-0.0430.014
call1000.000.050.010.6121,6614.000.018-0.0200.006
call1050.001.150.050.70267.000.000.016-0.0210.005
call1100.000.050.010.9971450.000.032-0.0500.009
put40.000.000.050.001.8560.000.00-0.006-0.0210.002
put45.000.002.150.001.6640.000.00-0.007-0.0220.002
put50.000.000.050.051.3591,2250.00-0.008-0.0210.003
put55.000.002.100.051.3637530.00-0.021-0.0510.007
put60.000.000.200.011.1081,0390.00-0.026-0.0490.008
put65.000.000.250.030.8682,80020.00-0.033-0.0460.009
put70.000.000.150.050.6393,42925.00-0.043-0.0420.012
put75.000.000.250.150.4703,19533.00-0.089-0.0550.021
put80.000.550.850.850.3711,25489.00-0.295-0.1010.044
put85.002.904.104.500.5276561.00-0.658-0.1090.047
put90.006.408.708.160.7391710.00-0.902-0.0480.022
put95.0012.2014.6015.511.2125.000.00-0.947-0.0380.014
put10016.7019.600.001.4410.000.00-0.980-0.0140.006
put10521.7024.6030.461.6460.000.00-0.983-0.0150.005
put11026.0029.6035.261.8330.000.00-0.985-0.0150.005

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-0510-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-11-058-KCurrent report2026-11-05SEC
2026-11-034Statement of changes in beneficial ownership of securities2026-10-30SEC
2026-10-134Statement of changes in beneficial ownership of securities2026-10-09SEC
2026-10-134Statement of changes in beneficial ownership of securities2026-10-09SEC
2026-10-134Statement of changes in beneficial ownership of securities2026-10-09SEC
2026-10-134Statement of changes in beneficial ownership of securities2026-10-09SEC
2026-10-134Statement of changes in beneficial ownership of securities2026-10-09SEC
2026-10-134Statement of changes in beneficial ownership of securities2026-10-09SEC
2026-10-138-KCurrent report2026-10-08SEC
2026-10-088-KCurrent report2026-10-08SEC
2026-10-024Statement of changes in beneficial ownership of securities2026-09-30SEC
2026-09-184Statement of changes in beneficial ownership of securities2026-09-17SEC
2026-09-024Statement of changes in beneficial ownership of securities2026-08-31SEC
2026-08-243Initial statement of beneficial ownership of securities2026-08-17SEC
2026-08-114Statement of changes in beneficial ownership of securities2026-08-07SEC
2026-08-0610-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-08-068-KCurrent report2026-08-06SEC
2026-08-068-KCurrent report2026-08-06SEC
2026-07-30SCHEDULE 13G/ASEC
2026-07-144Statement of changes in beneficial ownership of securities2026-07-10SEC
2026-07-144Statement of changes in beneficial ownership of securities2026-07-10SEC
2026-07-144Statement of changes in beneficial ownership of securities2026-07-10SEC
2026-07-144Statement of changes in beneficial ownership of securities2026-07-10SEC
2026-07-144Statement of changes in beneficial ownership of securities2026-07-10SEC
2026-07-144Statement of changes in beneficial ownership of securities2026-07-10SEC
2026-07-144Statement of changes in beneficial ownership of securities2026-07-10SEC
2026-07-144Statement of changes in beneficial ownership of securities2026-07-10SEC
2026-07-144Statement of changes in beneficial ownership of securities2026-07-10SEC
2026-07-143/A2026-06-15SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-080000
2026-070000
2026-060000
2026-05886.37K300
2026-040000
2026-030000
2026-02002.54M1
2026-010000
2025-120000
2025-110000

Institutional holders

Manager% owned
BlackRock, Inc.9.41%
VANGUARD CAPITAL MANAGEMENT LLC6.21%
VANGUARD PORTFOLIO MANAGEMENT LLC5.69%
STATE STREET CORP4.69%
STATE FARM MUTUAL AUTOMOBILE INSURANCE CO3.79%
GEODE CAPITAL MANAGEMENT, LLC3.21%
FIL Ltd2.58%
WELLINGTON MANAGEMENT GROUP LLP2.25%
MORGAN STANLEY2.12%
NORDEA INVESTMENT MANAGEMENT AB1.53%

Funds

Fund% owned
JPMorgan Ultra-Short Income ETF17.89%
VANGUARD INTERMEDIATE-TERM CORPORATE BOND INDEX FUND11.93%
iShares Convertible Bond ETF9.95%
PGIM Ultra Short Bond ETF8.23%
VANGUARD INSTITUTIONAL INTERMEDIATE-TERM BOND FUND7.49%
State Street(R) SPDR(R) Bloomberg Convertible Securities ETF7.12%
VANGUARD SHORT-TERM CORPORATE BOND INDEX FUND5.98%
VANGUARD INTERMEDIATE-TERM INVESTMENT-GRADE FUND5.63%
Permanent Portfolio4.77%
NYLIM MacKay Convertible Fund3.64%

OakChart. ZTS. Cached 15 minutes.